×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| Shukra Pharmaceuticals Limited | 147.35 | 53.87 | 132.70 | 0.12 | 889.0 | 92.8 |
| KOPRAN LTD. | 531.32 | 35.18 | 513.35 | 0.73 | 866 | 22.5 |
| WANBURY LTD. | 1,738.44 | 202.57 | 1,720.00 | 5.98 | 802 | 26.3 |
Shukra Pharmaceuticals Limited, with Security Code 524632, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.3 | 46.2 | 20.2 | 24.6 | 18.9 | 10.9 | 3.2 | 5.6 | 10.6 | 13.3 |
| Expenses | 2.0 | 42.6 | 19.8 | 19.6 | 9.3 | 6.5 | 2.4 | 4.9 | 6.6 | 5.9 |
| Operating Profit | 0.3 | 3.7 | 0.3 | 5.1 | 9.5 | 4.4 | 0.8 | 0.7 | 3.9 | 7.4 |
| OPM % | 12.42% | 7.89% | 1.67% | 20.65% | 50.53% | 40.74% | 25.36% | 11.99% | 37.2% | 55.65% |
| Other Income | 0.3 | 0.9 | 0.6 | 0.2 | 0.6 | 1.4 | 0.7 | 1.0 | 1.0 | 1.5 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 |
| Depreciation | 0.5 | 0.5 | 0.5 | 0.6 | 0.5 | 0.5 | 0.7 | 0.7 | 0.7 | 0.9 |
| Profit before tax | 0.0 | 4.0 | 0.4 | 4.7 | 9.5 | 5.2 | 0.8 | 0.9 | 4.1 | 7.6 |
| Tax % | -43.5% | 0.3% | -1.4% | 0.1% | -1.1% | -23.7% | -39% | -38.4% | -22.7% | -27.7% |
| Net Profit | 0.0 | 4.0 | 0.4 | 4.7 | 9.4 | 4.0 | 0.5 | 0.5 | 3.2 | 5.4 |
| EPS in Rs | 0.02 | 2.35 | 0.06 | 0.15 | 0.86 | 0.36 | 0.01 | 0.03 | 0.07 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 67% |
| 3 Years: | 88% |
| TTM: | -73% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 39% |
| 5 Years: | 109% |
| 3 Years: | 410% |
| TTM: | -56% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 48% |
| 5 Years: | 144% |
| 3 Years: | 258% |
| 1 Year: | 22% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|